Coagulase-negative staphylococci (CoNS) are among the most frequently recovered
bacteria in routine clinical care. Their incidence has steadily increased over the past …

Introduction Fosfomycin is a wide spectrum bactericidal antibiotic with a unique mode of
action, low toxicity, and good penetration in tissues with deep-seated infections, including …

Multidrug resistant Gram-negative bacteremia represents a therapeutic challenge clinicians
have to deal with. This concern becomes more difficult when causing germs are represented …

Acinetobacter baumannii (AB) has evolved over the last decades as a major problem in
carbapenem-resistant gram-negative nosocomial infections, associated with high mortality …

Pseudomonas aeruginosa is a pathogen frequently encountered in healthcare-associated
infections and immunocompromised patients. In bacteremia, this pathogen is associated …

Introduction Daptomycin is a bactericidal lipopeptide antibiotic approved for the treatment of
systemic infections (ie skin and soft tissue infections, bloodstream infections, infective …

Antibiotics are essential molecules for the treatment and prophylaxis of many infectious
diseases. However, drugs that combat microbial infections can become a human health …

Objectives Little is known regarding outcomes and optimal therapeutic regimens of
infections caused by Klebsiella pneumoniae carbapenemase-producing Klebsiella …

Multidrug-resistant (MDR) Enterobacterales are a priority health issue with few treatment
options. Recently, fosfomycin has been reconsidered for MDR bacterial infections …

Therapeutic options for infections caused by vancomycin-resistant enterococci are currently
suboptimal. Combination regimens where fosfomycin is used alongside existing treatments …